Open AccessPathogenetic therapy of systemic scleroderma
Author(s) -
И. Г. Салихов,
R. A. Bodrova,
L. E. Ziganshina
Publication year - 2001
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj84126
Subject(s) - scleroderma (fungus) , medicine , systemic scleroderma , connective tissue , connective tissue disease , fibrosis , systemic disease , pathology , dermatology , progressive systemic sclerosis , connective tissue disorder , systemic therapy , disease , autoimmune disease , cancer , breast cancer , inoculation
Systemic scleroderma (SSD) is a progressive polysyndromic disease with characteristic changes in the skin, musculoskeletal system, internal organs and widespread vasospastic disorders based on connective tissue lesions with predominant vascular fibrosis of the type of obliterating endarteriolitis.